Sichuan Huiyu Pharmaceutical Co., Ltd

This early-stage clinical trial is testing a new drug called HY07121 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose, understand how the body processes the drug, and see if it shows any early signs o…

This early-stage study is testing a new drug called HYP-6589 in adults with advanced solid tumors that cannot be surgically removed. The main goals are to find a safe dose, check for side effects, and see if the drug can shrink tumors. The study will test HYP-6589 alone and in co…

This study is testing a new drug called HY05350 for people with advanced solid tumors that have a specific protein called MSLN. The first part checks the drug's safety and finds the right dose, while the second part looks at how well it shrinks tumors. It's for adults whose cance…

This study is testing a new drug, HYP-2090PTSA, for people with advanced solid tumors that have a specific genetic change called a KRAS mutation. The first part aims to find a safe and effective dose. The second part will explore how well the drug works for certain cancers with a…

This study is testing a new drug called HY0001a in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. It is for adults with cancers like esophageal cancer, lung cancer, an…

This early-stage study is testing the safety of a new injection called HY-2003, designed to reduce fat under the chin. Researchers will give the injection to 30 adults with moderate to severe 'double chin' fat and compare it to a placebo and an existing treatment. The main goal i…